Log in

NASDAQ:VSCP - VirtualScopics Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume34,573 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
VirtualScopics, Inc. is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable reproducible measurement of minute changes that occur in anatomic structures in oncology, cardiology, neurology and musculoskeletal diseases. It has developed a system which enables the assessment of oncology patients per standard Response Evaluation Criteria in Solid Tumors criteria, while permitting the measurement of measures, including tumor volume, tumor metabolic rate through fluorodeoxyglucose-positron emission tomography and tumor mitotic rate through fluorodeoxyglucose-positron emission tomography or tumor cellular density through diffusion magnetic resonance imaging.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:VSCP
CUSIPN/A
Phone+1-585-2496231

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VSCP News and Ratings via Email

Sign-up to receive the latest news and ratings for VSCP and its competitors with MarketBeat's FREE daily newsletter.


VirtualScopics (NASDAQ:VSCP) Frequently Asked Questions

What is VirtualScopics' stock symbol?

VirtualScopics trades on the NASDAQ under the ticker symbol "VSCP."

Has VirtualScopics been receiving favorable news coverage?

Press coverage about VSCP stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. VirtualScopics earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for VirtualScopics.

What other stocks do shareholders of VirtualScopics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VirtualScopics investors own include NovaBay Pharmaceuticals (NBY), InterCloud Systems (ICLD), SLS International (SLS), Acer Therapeutics (ACER), Novavax (NVAX), InspireMD (NSPR), Unilife (UNISQ), Amarin (AMRN), Aralez Pharmaceuticals (ARLZ) and Arena Pharmaceuticals (ARNA).

What is VirtualScopics' official website?

The official website for VirtualScopics is http://www.virtualscopics.com/.

How can I contact VirtualScopics?

VirtualScopics' mailing address is 500 Linden Oaks, ROCHESTER, NY 14625-2823, United States. The medical equipment provider can be reached via phone at +1-585-2496231.


MarketBeat Community Rating for VirtualScopics (NASDAQ VSCP)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  114
MarketBeat's community ratings are surveys of what our community members think about VirtualScopics and other stocks. Vote "Outperform" if you believe VSCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel